| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |